About Us

HealthActCHQ's portfolio of surveys represents scientific work that spans more than two decades. Our surveys are used throughout the world in clinical trials, patient registries, and academic, private and government funded research programs. All HACHQ surveys are rigorously developed to include direct input in the development of concepts and items from both children and adults (as warranted) - varying in diagnosis and its related subtypes, disease/condition severity, treatment status and time of onset/diagnosis - as well as feedback from clinical experts. New survey development is conducted according to the current FDA PRO Guidance and EMA Functional and Co-Primary Endpoint Guidance.

HealthActCHQ has conducted the translation of more than 165 versions of the CHQ in over 70 languages. We are the developers and exclusive licensor for the AIM-A, an industry-leading adult ADHD functional outcomes survey used internationally and now available in 13 languages, as well as the AIM-C, the only published pediatric survey to assess the impact of ADHD on children and their families.

Manuscripts, posters, and abstract citations on the development, validation and applied uses of the surveys are searchable by key words on the HACHQ Bibliography tab at our website.

Use of all HealthActCHQ surveys requires a paid limited use licensure. All users are asked to register and pay for each specific project.

You can register proposed research without any obligation to purchase. Ongoing management, support, and scientific development for all HACHQ surveys, short-forms, translations, and utility-based scoring are funded exclusively by licensing fees.